SEC Filing Details

SEC Filing Details

Document Details

Filing Date
Apr 27, 2023
Document Date
Dec 31, 2022
Form Description
An annual report to security holders
Filing Group
Annual Filings
iTeos Therapeutics

For investors

Discover more about iTeos Therapeutics, our science, and our high potential for investment.

Cancer Cells graphics

At iTeos we are pioneering the discovery and development of a new generation of highly differentiated immuno-oncology therapeutics.

Our differentiated development approach is driven by biologic rationale and clinical need utilizing our IO candidates in intra-portfolio combinations and with programs of external collaborators.

Driven by a culture of scientific innovation, collaboration and excellence, together we discover and deliver breakthrough immunotherapies to improve and extend the lives of people with cancer.